Table of Contents
1 Industry Outlook 9
1.1 Industry Overview 9
1.2 Total Addressable Market 10
2 Report Outline 13
2.1 Report Scope 13
2.2 Report Summary 13
2.3 Research Methodology 14
2.4 Report Assumptions 14
3 Market Snapshot 16
3.1 Market Definition - Infoholic Research 16
3.2 Segmented Addressable Market 16
3.3 Industry Trends 17
3.4 Related Markets 18
3.4.1 Transdermal Drug Delivery 18
3.4.1.1 Trends of cardiovascular drugs market 19
3.4.2 Pulmonary Drug Delivery Systems (PDDS) 19
3.4.3 Insulin Pumps 20
4 Market Outlook 22
4.1 Cost comparison of EpiPen and its Alternatives 22
4.2 Market Segmentation 22
4.3 Porter 5(Five) Forces 23
4.4 PEST Analysis 25
5 Market Characteristics 26
5.1 Market Dynamics 26
5.1.1 Drivers 26
5.1.1.1 Increasing prevalence of Anaphylaxis 26
5.1.1.2 Rising incidence of chronic disease 27
5.1.1.3 Increased Development Biologics / Biosimilars 28
5.1.1.4 Growing demand for home care 28
5.1.2 Opportunities 28
5.1.2.1 Increase in healthcare spending 28
5.1.2.2 Opportunities in emerging market 29
5.1.2.3 Favorable government policies 29
5.1.3 Restraints 30
5.1.3.1 Competition among major vendors 30
5.1.3.2 Increased product recall 30
5.1.3.3 High product pricing 30
5.2 DRO - Impact Analysis 31
5.3 Key Stakeholders 32
6 Application: Market Size and Analysis 33
6.1 Overview 33
6.2 Anaphylaxis 34
6.3 Multiple Sclerosis 35
6.4 Rheumatoid Arthritis 36
6.5 Diabetes 37
6.6 Others 38
7 Product Type: Market Size and Analysis 40
7.1 Overview 40
7.2 Disposable autoinjector 40
7.3 Reusable autoinjectors 41
8 Regions: Market Size and Analysis 43
8.1 Overview 43
8.2 North America 44
8.2.1 Overview 44
8.3 Europe 45
8.3.1 Overview 45
8.4 Asia Pacific 46
8.4.1 Overview 46
8.5 Rest of the World 48
8.5.1 Overview 48
9 Competitive Landscape 49
10 Vendors Profile 51
10.1 Amgen Inc. 51
10.1.1 Overview 51
10.1.2 Geographic Presence 54
10.1.3 Business Focus 55
10.1.4 SWOT Analysis 56
10.1.5 Business Strategies 57
10.2 Becton Dickinson and Company 57
10.2.1 Overview 57
10.2.2 Business Units 60
10.2.3 Geographic Revenue 61
10.2.4 Business Focus 61
10.2.5 SWOT Analysis 61
10.2.6 Business Strategies 62
10.3 Mylan N.V. 62
10.3.1 Overview 62
10.3.2 Business Segments 64
10.3.3 Geographic Presence 66
10.3.4 Business Focus 66
10.3.5 SWOT Analysis 66
10.3.6 Business Strategies 67
10.4 Bayer AG 67
10.4.1 Overview 67
10.4.2 Business Units 69
10.4.3 Geographic Presence 70
10.4.4 Business Focus 71
10.4.5 SWOT Analysis 71
10.4.6 Business Strategies 72
10.5 Eli Lilly & Company Ltd. 72
10.5.1 Overview 72
10.5.2 Business Units 74
10.5.3 Geographic Revenue 75
10.5.4 Business Focus 75
10.5.5 SWOT Analysis 75
10.5.6 Business Strategies 76
10.6 Novartis AG 76
10.6.1 Overview 76
10.6.2 Business Units 80
10.6.3 Geographic Presence 80
10.6.4 Business Focus 81
10.6.5 SWOT Analysis 81
10.6.6 Business Strategies 82
1 Vendors Profile 83
1.1 Ypsomed Holding AG 83
1.1.1 Overview 83
1.2 Biogen Pharmaceuticals 84
1.2.1 Overview 84
1.3 Pfizer Inc. 85
1.3.1 Overview 85
1.3.2 Highlights 87
1.4 Teva Pharmaceutical Industries Ltd. 87
1.4.1 Overview 87
1.5 Antares Pharma' Inc. 89
1.5.1 Overview 89
1.6 Johnson & Johnson 90
1.6.1 Overview 90
1.7 AbbVie Inc. 91
1.7.1 Overview 91
2 Annexure 94
Abbreviations 94
?